Total Payments
$22,286
2024 Payments
$1,320
Companies
40
Transactions
884
Medicare Patients
7,406
Medicare Billing
$1.4M
Payment Breakdown by Category
Food & Beverage$22,027 (98.8%)
Education$258.45 (1.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $22,027 | 873 | 98.8% |
| Education | $258.45 | 11 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $3,674 | 165 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $3,529 | 129 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,426 | 96 | $0 (2021) |
| Advanced Respiratory, Inc | $1,380 | 54 | $0 (2021) |
| GENZYME CORPORATION | $1,360 | 38 | $0 (2024) |
| Philips Electronics North America Corporation | $1,304 | 76 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $1,029 | 26 | $0 (2024) |
| Lilly USA, LLC | $715.89 | 30 | $0 (2024) |
| Electromed, Inc. | $619.06 | 21 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $595.43 | 21 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,320 | 50 | GENZYME CORPORATION ($246.67) |
| 2023 | $2,918 | 99 | GlaxoSmithKline, LLC. ($440.22) |
| 2022 | $2,713 | 102 | GlaxoSmithKline, LLC. ($595.16) |
| 2021 | $3,548 | 142 | GlaxoSmithKline, LLC. ($900.36) |
| 2020 | $2,963 | 133 | Boehringer Ingelheim Pharmaceuticals, Inc. ($557.89) |
| 2019 | $3,328 | 133 | Boehringer Ingelheim Pharmaceuticals, Inc. ($743.45) |
| 2018 | $3,069 | 117 | Boehringer Ingelheim Pharmaceuticals, Inc. ($710.36) |
| 2017 | $2,428 | 108 | GlaxoSmithKline, LLC. ($497.20) |
All Payment Transactions
884 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.64 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $47.56 | General |
| Category: Medical Device | ||||||
| 12/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.07 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $32.39 | General |
| Category: RESPIRATORY | ||||||
| 11/01/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.24 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $28.99 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $28.57 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/27/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.76 | General |
| Category: Immunology | ||||||
| 09/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $32.28 | General |
| Category: RESPIRATORY | ||||||
| 09/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.78 | General |
| Category: Immunology | ||||||
| 09/11/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Diabetes | ||||||
| 09/07/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $27.63 | General |
| Category: IMMUNOLOGY | ||||||
| 07/31/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: Diabetes | ||||||
| 07/25/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: Airway Clearance Device | ||||||
| 07/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $34.12 | General |
| Category: DIABETES | ||||||
| 07/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: Diabetes | ||||||
| 07/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $29.63 | General |
| Category: RESPIRATORY | ||||||
| 06/26/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Diabetes | ||||||
| 05/29/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Diabetes | ||||||
| 05/29/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $3.72 | General |
| Category: Diabetes | ||||||
| 05/28/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $4.77 | General |
| Category: Diabetes | ||||||
| 05/22/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: Airway Clearance Device | ||||||
| 05/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: RESPIRATORY | ||||||
| 05/09/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,714 | 5,951 | $568,246 | $298,326 |
| 2022 | 15 | 1,796 | 6,688 | $625,132 | $331,882 |
| 2021 | 17 | 1,991 | 7,550 | $709,421 | $389,143 |
| 2020 | 18 | 1,905 | 6,185 | $660,442 | $388,488 |
Total Patients
7,406
Total Services
26,374
Medicare Billing
$1.4M
Procedure Codes
66
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 239 | 1,502 | $211,628 | $110,573 | 52.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 282 | 660 | $107,060 | $78,249 | 73.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 276 | 336 | $89,230 | $53,137 | 59.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 93 | 93 | $20,319 | $14,355 | 70.6% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 43 | 2,550 | $38,250 | $9,795 | 25.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 218 | 224 | $28,522 | $7,831 | 27.5% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 129 | 132 | $26,400 | $6,719 | 25.5% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 129 | 132 | $26,400 | $5,031 | 19.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 25 | 28 | $3,930 | $3,014 | 76.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 30 | $4,044 | $2,454 | 60.7% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 81 | 88 | $4,213 | $2,308 | 54.8% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 12 | 12 | $1,800 | $1,570 | 87.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 37 | 37 | $1,850 | $1,331 | 72.0% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 37 | 37 | $1,850 | $810.30 | 43.8% |
| 94640 | Inhalation treatment for airway obstruction or sputum production | Office | 2023 | 78 | 78 | $2,150 | $716.82 | 33.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 12 | 12 | $600.00 | $431.76 | 72.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 261 | 1,769 | $251,422 | $118,621 | 47.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 308 | 677 | $109,260 | $81,227 | 74.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 324 | 401 | $106,066 | $74,276 | 70.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 78 | 78 | $17,327 | $12,765 | 73.7% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 50 | 2,941 | $44,115 | $12,234 | 27.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 202 | 208 | $25,913 | $7,801 | 30.1% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 122 | 126 | $25,200 | $7,138 | 28.3% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2022 | 122 | 126 | $25,200 | $5,225 | 20.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 29 | 35 | $4,885 | $3,459 | 70.8% |
About Dr. Maurice Alwaya, MD
Dr. Maurice Alwaya, MD is a Pulmonary Disease healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376576694.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Maurice Alwaya, MD has received a total of $22,286 in payments from pharmaceutical and medical device companies, with $1,320 received in 2024. These payments were reported across 884 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($22,027).
As a Medicare-enrolled provider, Alwaya has provided services to 7,406 Medicare beneficiaries, totaling 26,374 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Brooklyn, NY
- Active Since 07/09/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RP1001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1376576694
Products in Payments
- DUPIXENT (Biological) $2,083
- TRELEGY ELLIPTA (Drug) $1,450
- STIOLTO RESPIMAT (Drug) $1,128
- NUCALA (Biological) $1,059
- OFEV (Drug) $974.48
- FASENRA (Drug) $890.84
- The Vest System Model 105 Home Care (Device) $875.88
- (8874) inCourage (Device) $862.85
- SYMBICORT (Drug) $746.35
- JARDIANCE (Drug) $678.56
- ELIQUIS (Drug) $666.08
- SMARTVEST (Device) $619.06
- ANORO (Drug) $528.93
- FASENRA (Biological) $408.03
- MOUNJARO (Drug) $400.00
- Xolair (Biological) $346.96
- ANORO ELLIPTA (Drug) $303.51
- YUPELRI (Drug) $297.62
- ACTHAR (Biological) $297.26
- INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) $293.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Brooklyn
Dr. Chaim Bernstein, M.d, M.D
Pulmonary Disease — Payments: $254,754
Pulmonary Disease $254,754
Dr. Boris Sagalovich, Md, MD
Pulmonary Disease — Payments: $253,577
Pulmonary Disease $253,577
Aron Rubin, Md, MD
Pulmonary Disease — Payments: $17,669
Pulmonary Disease $17,669
Elliott Bondi, Md, MD
Pulmonary Disease — Payments: $16,602
Pulmonary Disease $16,602
Dr. Mohammad Zaman, Md, MD
Pulmonary Disease — Payments: $12,861
Pulmonary Disease $12,861
Erum Zahid, Md, MD
Pulmonary Disease — Payments: $11,899
Pulmonary Disease $11,899